PHARMAMAR HA ACTUALIZADO FASE III LAGOON LURBINECTEDIN Y SE RETRASA SU CONCLUSIÓN HASTA ABRIL 2026.
26 enero 2021
Aplidin , UK , The Guardián : PharmaMar Said It Was in Talks With Various Regulatory Agencies - The Most Advanced Ones Being With The Spanish and British Regulators - To Start Phase III Trials .
Entrada más reciente
Entrada antigua
Inicio